Medilytix Bureau:

The Serum Institute of India (SII) has communicated to the Union government it will supply around 20 crore doses in September of the vaccine against the coronavirus disease (Covid-19) developed by Oxford University-Astrazeneca, which the Pune-based company is manufacturing as Covishield in India. This is double the number of doses which the SII earlier told the Centre will be delivered that month.
“We have further enhanced the production capacity and will be able to supply approximately 20 crore doses of Covishield to the government and private hospitals,” Prakash Kumar Singh, SII’s director, government and regulatory affairs, wrote to the Union ministry of health and family welfare (MoHFW), according to officials.
In a production plan submitted to the central government in May, the SII put at 10 crore each, its production capacity for Covishield, for both August and September. This month, the world’s largest vaccine manufacturer has supplied 12 crore doses of the vaccine to the Centre and private hospitals.

Leave a Reply

Your email address will not be published. Required fields are marked *